Webcast CME

Biologic Therapies VII: Precision Medicine in the Biologic Era


Cases with the Masters:
Clinical Challenges in Rheumatoid Arthritis

Print this Content

Release Date:   June 7, 2017
Expiration Date:   June 7, 2019

Estimated Time of Completion:   45 minutes

Description

Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.

Cases With Masters: Clinical Challenges in Rheumatoid Arthritis will review several cases examining risk factors associated with developing Rheumatoid Arthritis as well as potential interventions at critical stages in the development of IMIDs.

Learning Objectives

  1. Describe the role of behavior modification in treating or delaying progression of RA.
  2. Critically appraise the data on cofactors favoring progression of ‘pre-RA’ states to clinical disease.

Target Audience

The online series is designed for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Directors and Faculty

Activity Directors

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

John J. Cush, MD
Director of Clinical Rheumatology
Baylor Research Institute
Executive Editor, RheumNow.com
Dallas, TX

V. Michael Holers, MD
Scoville Professor and Head, Division of Rheumatology
Departments of Medicine and Immunology
University of Colorado Anschutz
Medical Campus
Aurora, CO

Arthur Kavanaugh, MD
Professor of Medicine
Director, Center for Innovative Therapy
Division of Rheumatology, Allergy, and Immunology
University of California, San Diego
San Diego, CA

Jonathan Kay, MD
Professor of Medicine
University of Massachusetts Medical School
Director of Clinical Research
Division of Rheumatology
UMass Memorial Medical Center
Worcester, MA

Edward Keystone, MD
Professor of Medicine
University of Toronto
Director
The Rebecca MacDonald Centre For Arthritis
Mount Sinai Hospital
Toronto, Canada

Iain McInnes, FRCP, PhD, FRSE, FMedSci
Muìrhead Professor of Medicine
ARUK Professor of Rheumatology
Director of Institute of Infection Immunity and Inflammation
College of Medical, Veterinary and Life Sciences
University of Glasgow
Glasgow, Scotland

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:


Leonard H. Calabrese, DO
  AbbVie Pharmaceuticals; Bristol Myers Squibb;
Genentech/ Roche; Janssen
Consulting; Teaching and Speaking
  GlaxoSmithKline; Pfizer, Inc.; UCB Consulting
  Crescendo Teaching and Speaking
V. Michael Holers, MD
  Janssen Independent contractor (including contracted research)
M. Elaine Husni, MD, MPH
  AbbVie Pharmaceuticals; Genentech; Janssen Consulting
  Amgen; Bristol-Myers Squibb; Genzyme/Sanofi; Lilly, Regeneron Consulting;
Membership on advisory committee or review panels
  Novartis Pharmaceuticals Consulting; Teaching and Speaking
  Pfizer, Inc. Membership on advisory committee or review panels
Arthur Kavanaugh, MD
  Pfizer, Inc. Consulting
Independent contractor (including contracted research)
  Abbott Laboratories; Amgen; Bristol-Myers Squibb Co.; Centocor; UCB Independent contractor (including contracted research)
Jonathan Kay, MD
  AbbVie Pharmaceuticals; Genentech; Lilly;
Pfizer, Inc.; UCB
Consulting
Independent contractor (including contracted research)
  Alexion; Fast Forward Pharmaceuticals, B.V.; Samsung Bioepis Membership on advisory committee or review panels
  Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Co.; Epirus Biopharmaceuticals, Inc.; GlaxoSmithKline; Hospira; Janssen; Merck Sharp & Dohme Limited; Myriad Genetics, Inc.; Novartis Pharmaceuticals Consulting
  Ardea Independent contractor (including contracted research)
  Roche Pharmaceuticals Independent contractor (including contracted research)
Membership on advisory committee or review panels
Edward Keystone, MD
  Merck Consulting;
Membership on advisory committee or review panels
  AstraZeneca Pharmaceuticals; Janssen; Pfizer, Inc. Consulting;
Membership on advisory committee or review panels; Teaching and Speaking
  Lilly Board Membership; Consulting;
Teaching and Speaking
  Crescendo Consulting
Iain McInnes, FRCP, PhD, FRSE, FmedSci
  AbbVie Pharmaceuticals; Janssen; MSD; Novartis Consulting
  Bristol-Myers Squibb Co.; Pfizer, Inc.; UCB Consulting;
Independent contractor (including contracted research)
  Roche Pharmaceuticals Consulting; Membership on advisory committee or review panels

The following faculty has indicated that he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

John J. Cush, MD

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb Co.
Celgene Corporation
Crescendo Bioscience, Inc.
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
UCB, Inc.

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the R.J. Fasenmyer Center for Clinical Immunology.